4//SEC Filing
Keane Raymond T 4
Accession 0001127602-13-011540
CIK 0000884731other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:42 PM ET
Size
7.4 KB
Accession
0001127602-13-011540
Insider Transaction Report
Form 4
Keane Raymond T
SVP General Counsel & CCO
Transactions
- Award
Restricted Stock Units
2013-03-19+14,250→ 14,250 totalExp: 2023-03-19→ Common Stock (14,250 underlying) - Award
Employee Stock Option (Right to Buy)
2013-03-19+28,500→ 28,500 totalExercise: $20.89Exp: 2023-03-19→ Common Stock (28,500 underlying)
Footnotes (3)
- [F1]Options vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016
- [F2]Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- [F3]Restricted Stock Units vest as to 33-1/3% of the award on each of March 19, 2014, March 19, 2015 and March 19, 2016
Documents
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeother
Related Parties
1- filerCIK 0001448434
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:42 PM ET
- Size
- 7.4 KB